Abstract: The invention provides a composition comprising (S) 2-amino-1-(4-chloro-phenyl)-1-[4-(1H-pyrazol-4-yl)-phenyl]-ethanol, wherein the composition is either substantially free of (R) 2-amino-1-(4-chloro-phenyl)-1-[4-(1H-pyrazol-4-yl)-phenyl]-ethanol or the composition contains a mixture of the (S) and (R) enantiomers in which the (S) enantiomer predominates. Also provided are processes for the preparation of the (S) 2-amino-1-(4-chloro-phenyl)-1-[4-(1H-pyrazol-4-yl)-phenyl]-ethanok novel process intermediates and methods for making the novel process intermediates.
Type:
Application
Filed:
July 11, 2011
Publication date:
November 3, 2011
Applicants:
ASTEX THERAPEUTICS LIMITED, CANCER RESEARCH TECHNOLOGY LIMITED, THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL
Inventors:
Steven John WOODHEAD, David Charles REES, Martyn FREDERICKSON, Kyla Merriom GRIMSHAW
Abstract: The invention relates to a process for the enantioselective preparation of tolterodiine and analogues and salts thereof comprises the steps of:
Abstract: The present invention relates to a process for the asymmetric hydrogenation of a ketonic compound and derivative.The invention relates to the use of optically active metal complexes as catalysts for the asymmetric hydrogenation of a ketonic compound and derivative.
Type:
Grant
Filed:
March 24, 1999
Date of Patent:
December 26, 2000
Assignee:
Rhodia Chimie
Inventors:
Francois Mathey, Frederic Robin, Francois Mercier, Michel Spagnol
Abstract: A method of preparing optically active methadones comprises an enzymatic process for the resolution of 1-dialkyl-amino-2-propanol and conversion of the enantiomers to the optically active methadones in high enantiomeric purity.
Type:
Grant
Filed:
April 9, 1999
Date of Patent:
November 7, 2000
Assignee:
Salford Ultrafine Chemicals & Research Ltd.
Inventors:
Feodor Scheinmann, Jonathan David Hull, Nicholas John Turner
Abstract: A 5H-dibenzo [a,d] cycloheptenylidene derivative and a 5H-dibenzo [1,d] cycloheptenylidene derivative represented by the following general formula [I]: ##STR1## wherein X is --CH.sub.2 --CH.sub.2 -- or --CH.dbd.CH--; R.sub.1 and R.sub.2 are alkyl groups, aralkyl groups, aromatic groups or heterocyclic groups, R.sub.3 and R.sub.4 are hydrogen atoms, alkyl groups, alkoxy groups or halogen atoms; and Ar.sub.1 is an aromatic group or a heterocyclic group, process for producing those derivatives, and electrophotographic photosensitive member using the same.
Abstract: Disclosed are platinum (IV) chelates derived from substituted amides. The chelates result from the reaction under mild conditions of potassium chloroplatinate (II) and the appropriate amide. The chelate transdichloro-cis-bis(dimethylacetamide-C,O) was prepared, fully characterized and exemplified in preparation of the antihistamine diphenhydramine hydrochloride.